Oncternal Therapeutics In... (ONCT)
NASDAQ: ONCT
· Real-Time Price · USD
0.53
-0.16 (-23.63%)
At close: Dec 02, 2024, 10:00 PM
Oncternal Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -8.46M | -8.56M | -8.39M | -9.16M | -9.86M | -8.97M | -11.49M | -11.4M | -11.13M | -11.74M | -9.9M | -8.07M | -9.63M | -7.68M | -5.95M |
Depreciation & Amortization | n/a | n/a | n/a | 329K | 75K | 37K | n/a | -75K | 35K | 65K | 44K | 44K | 43K | 42K | 40K |
Stock-Based Compensation | 1.85M | 1.38M | 1.36M | 2.22M | 1.72M | 1.68M | 1.89M | 1.8M | 1.97M | 1.68M | 1.98M | 1.71M | 1.49M | 1.84M | 838K |
Other Working Capital | -699K | 1.1M | -449K | 1.85M | 3.01M | -1.81M | -10K | 175K | -2.79M | 2.75M | -1.16M | 487K | -18K | -921K | -1.66M |
Other Non-Cash Items | 1.06M | 757K | 771K | -342K | -283K | -430K | -404K | 35K | 35K | 65K | 44K | 44K | 43K | 42K | 40K |
Deferred Income Tax | n/a | n/a | n/a | 112K | -75K | -37K | n/a | n/a | -35K | -65K | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -1.4M | 1.54M | -135K | 869K | 2.92M | -1.55M | -963K | 636K | -2.85M | 2.87M | -724K | -300K | 1.72M | -1.8M | -915K |
Operating Cash Flow | -6.95M | -5.82M | -7.44M | -6.42M | -5.51M | -9.26M | -10.97M | -9M | -11.97M | -7.13M | -8.61M | -6.62M | -6.38M | -7.61M | -5.99M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | -6.29M | -10.03M | -11.81M | -15.35M | -15.15M | -22.05M | -26.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 13.65M | 12.1M | 17.25M | 10M | 20M | 29M | 6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | 5.81M | 7.22M | -1.81M | 4.66M | 13.85M | n/a | -26.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 13.65M | 5.81M | 7.22M | -1.81M | 4.66M | 13.85M | -16.05M | -26.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | -87K | -1K | -49K | -1K | -105K | n/a | -3K | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.7M | n/a | n/a | 1K | 97K | 60K | 459K |
Financial Cash Flow | n/a | n/a | -87K | -1K | -49K | -1K | 1.12M | 2.01M | 3.69M | 3.87M | n/a | 1K | 97K | 60K | 459K |
Net Cash Flow | 6.7M | -14K | -301K | -8.23M | -907K | 4.59M | -25.9M | -33.49M | -8.27M | -3.26M | -8.61M | -6.62M | -6.28M | -7.55M | -5.53M |
Free Cash Flow | -6.95M | -5.82M | -7.44M | -6.42M | -5.51M | -9.26M | -10.97M | -9M | -11.97M | -7.13M | -8.61M | -6.62M | -6.38M | -7.61M | -5.99M |